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ABSTRACT
Elucidating Mechanisms of
Canonical Wnt – ephrin-B Crosstalk
William Tyler Koch
Throughout development, canonical Wnt signaling contributes to the formation
and maintenance of a wide array of cells, tissues, and organs. Dys-regulated Wnt
signaling during embryonic development is implicated in developmental defects known
as neurochristopathies, including craniofacial and heart defects, as well as defects in
neural development. Due to its roles in stem cell maintenance and self-renewal, tissue
homeostasis, and regeneration, aberrant Wnt signaling in adult tissues can result in
various forms of cancer, including colorectal cancer, breast cancer, lung cancer, and
gastro-intestinal cancer, among others. Dys-regulated Wnt signaling is also implicated
in other pathologies including bone disease, and metabolic diseases, such as Type II
diabetes. Our lab has previously identified a novel crosstalk between canonical Wnt
signaling and ephrin signaling. Ephrin signaling occurs through the interaction of ephrin
ligands and Eph receptor tyrosine kinases, and is bidirectional. Due to the roles of
ephrin signaling in tissue development and maintenance, aberrant ephrin signaling is
implicated in many diseases including bone remodeling diseases, diabetes, and cancer.
The molecular mechanism of the crosstalk between canonical Wnt signaling and ephrinB signaling remains unknown. β-catenin is a key intracellular effector of canonical Wnt
signaling that transduces the signal to the nucleus, where β-catenin interacts with the
TCF/LEF transcription factors and activates transcription of target genes. Due to its
central role in transducing the canonical Wnt signal to the nucleus, we predict that
ephrin-B signaling antagonizes canonical Wnt signaling by affecting the stability and/or
sub-cellular localization of β-catenin, or the interaction between β-catenin and TCF/LEF
transcription factors. By employing mouse ephrin-B constructs in human cell lines, we
show that the canonical Wnt - ephrin-B crosstalk is conserved between frogs and
mammals. We also found that ephrin-B antagonism of canonical Wnt signaling is likely
independent of ubiquitin proteasome system (UPS)-mediated degradation of β-catenin.
Furthermore, confocal immunofluorescence microscopy revealed that overexpression of
ephrin-B in HEK293T cells treated with lithium chloride (LiCl) seems to promote
membrane localization of β-catenin, particularly at the apical Z sections. These results
suggests that re-localization of β-catenin to the cell membrane may contribute to the
ephrin-B antagonism of canonical Wnt signaling.
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We stare straight into nothing
But we call it all the same
-

Adam Granduciel

iv

Acknowledgements
There are so many people to thank, but only so many words to express my
gratitude for all of their support. I believe in humanity, and these humans and their
humanity made my personal growth possible.
I would like to thank my advisor, Dr. Shuo Wei, for providing this opportunity,
sharing his knowledge, and supporting me in this work. I learned so much just by being
in your presence and working alongside you, watching and listening to you evaluate
evidence and plot out next steps. You always challenged me to be my best, and I failed
to see that in certain moments. I am so grateful for all of the support you gave me: I
owe you some pie and coffee!
I would like to thank the advisor of my undergraduate research at James
Madison University, Dr. Chris Rose, for inspiring me to pursue research in cell and
developmental biology and nurturing my passion at a critical time. You shared your
confidence in my ability when others had doubted my academic potential and
encouraged me to pursue my passion for biology and research.
I would like to thank the members of my graduate committee, Dr. Ashok Bidwai
and Dr. Clif Bishop for their advice and support of this thesis. Dr. Bidwai, you always
knew how to calm my nerves and get me to relax. Dr. Bishop, your stories were always
entertaining and a great distraction from our serious work.
I would like to thank the past and present members of Dr. Wei’s Lab. Dr.
Harinathichai Bhahudhanapati, your kindness and patience are transcendent, and
rivaled only by your love of movies and 24-hour TV news. Dr. Laura Christian, you
taught me all the techniques I needed to perform this research, and you will always be a
nerdier nerd than me. Dr. Jeijing Li, you helped me solve one of the biggest mysteries
in this thesis; some PBS dried onto my microscope slides. Your positive nature and
humor are infectious. Mark Perfetto (Ph.D. candidate), you were always open to spitball ideas, and I could always confide in you. Your passion for knowledge is matched
only by your sarcasm. Shashwati Bhattacharya, M.S., you always knew how to
convince me that everything would work out in the end.
I would like to thank the undergraduate researchers, Carlos Nathan and
Crestyn White. You guys are outstanding, and I learned so much from sharing
knowledge with you.
I would like to thank West Virginia University and the Department of Biology.
Finally, I would like to thank my family and friends without whom I would be
completely lost.

v

Table of Contents
Chapter 1: Introduction .......................................... p.1-28
1.1: Canonical Wnt Signaling
1.1.1: Canonical Wnt Signaling .................................................... p.1
1.1.2: Dual Roles of β-catenin: β-catenin Structure and
Function ............................................................................ p.3
1.1.3: Regulation of β-catenin Stability......................................... p.6
1.1.4: β-catenin Subcellular Localization.................................... p.10

1.2: Ephrin Signaling
1.2.1: Ephrin Signaling ............................................................... p.12

1.3: Canonical Wnt – ephrin-B Crosstalk
1.3.1: Evidence of Canonical Wnt – ephrin-B Crosstalk............. p.21
1.3.2: Regulators of β-catenin Stability and Localization............ p.26
1.3.3: c-Jun N-terminal kinase 1 and 2 (JNK1, JNK2) ............... p.26

Chapter 2: Specific Aims ..................................... p.29-31
2.1: Specific Aims ...................................................................... p.29
2.2: Specific Aims Approaches .................................................. p.30

Chapter 3: Methods .............................................. p.32-34
Chapter 4: Results ................................................ p.35-52
Chapter 5: Discussion.......................................... p.53-55
Chapter 6: Works Cited ........................................ p.56-66

vi

List of Figures
Figure 1: β-catenin ARM Domain Interactors .............................................................. p.5
Figure 2: Canonical Wnt Signaling .............................................................................. p.8
Figure 3: Wnt Signaling in the Nucleus ....................................................................... p.9
Figure 4: Eph/ephrin Domain Organization and Signaling Modes ............................ p.16
Figure 5: Eph/ephrin Complexes and Receptor Clustering, and
Downstream Molecular Pathways and Cellular Responses ..................... p.19
Figure 6: Canonical Wnt and Eph/ephrin Interactions in the
Intestinal Stem Cell Niche and Colorectal Cancer Progression ................ p.23
Figure 7: Wild-type ephrin-B and ephrin-B1ΔC Inhibit Wnt3a – Induced
Reporter Activity ....................................................................................... p.24
Figure 8: Regulation of the Wnt Signaling Axis ......................................................... p.25
Figure 9: Ephrin-B Signaling Activates c-Jun N-terminal kinase (JNK) .................... p.27
Figure 10: Proposed Models for JNK-mediated ephrin-B Antagonism
of Canonical Wnt Signaling ..................................................................... p.28
Figure 11: Wnt3a Overexpression is Not Sufficient to Induce Reporter Activity ........ p.37
Figure 12: Wnt8 Overexpression is Not Sufficient to Induce Reporter Activity .......... p.38
Figure 13: Wild-type β-catenin Overexpression Induces Reporter Activity ................ p.39
Figure 14: ephrin-B1ΔC Inhibits Wild-type β-catenin – Induced Reporter Activity ..... p.40
Figure 15: LiCl Induces Reporter Activity .................................................................. p.41
Figure 16: ephrin-B1ΔC Inhibits LiCl – Induced Reporter Activity ............................. p.42
Figure 17: β-catenin* Overexpression Induces Reporter Activity .............................. p.43
Figure 18: ephrin-B1ΔC Inhibits β-catenin* – Induced Reporter Activity ................... p.44
Figure 19: ephrin-B Signaling Affects Levels of Total Cellular β-catenin ................... p.45
Figure 20: ephrin-B Signaling Affects Levels of Total Cellular β-catenin ................... p.46
Figure 21: LiCl and ephrin-B Signaling Increase Levels of Total Cellular
E-cadherin Independently and Co-Treatment Does Not Influence
this Effect................................................................................................ p.47

vii

List of Figures
Figure 22: Subcellular Localization of β-catenin in Response to
ephrin-B Signaling in Apical, Middle, and Basal Z Sections .................... p.48
Figure 23: Subcellular Localization of β-catenin in Response to
ephrin-B Signaling in Apical Z Sections ................................................... p.49
Figure 24: Subcellular Localization of β-catenin in Response to
ephrin-B Signaling in Middle Z Sections .................................................. p.50
Figure 25: Subcellular Localization of β-catenin in Response to
ephrin-B Signaling in Basal Z Sections ................................................... p.51
Figure 26: Inhibition of c-Jun N-terminal kinase (JNK) Inhibits
LiCl – Induced Reporter Activity and Enhances the ephrin-B1ΔC
Inhibition of LiCl – Induced Reporter Activity .......................................... p.52

1

Chapter 1: Introduction
1.1: Canonical Wnt Signaling
1.1.1: Canonical Wnt Signaling
There are 19 identified mammalian Wnt homologs, which include 22 cysteine
residues whose spacing and arrangement is highly conserved, a signal sequence for
secretion, and potential glycosylation sites

(Kikuchi, 2011; Mikels, 2006)

. Wnt ligands do not

function as a classical morphogen by establishing a chemical gradient, but instead
mediate close range signaling between cells that are close to one another

(Clevers, 2012)

.

Wnt ligands are palmitoylated in the endoplasmic reticulum (ER) by the Porcupine
(Porc) enzyme, and are glycosylated to ensure proper secretion
Port, 2010; Herr, 2012; Clevers, 2012)

(Takada, 2006; Lorenowicz, 2009;

. Palmitoylated Wnt ligands are transported to the Golgi

network where they bind to the Evi/Wntless multi-pass transmembrane protein
2006; Lorenowicz, 2009; Port, 2010; Herr, 2012; Clevers, 2012)

.

(Takada,

The Wnt/Evi/Wntless complexes are

secreted from the Golgi network in endosomal vesicles, which transport Wnt ligands to
the plasma membrane to be secreted from the cell

(Takada, 2006; Lorenowicz, 2009; Port, 2010; Herr,

2012; Clevers, 2012)

. Wnt ligands were first found to bind the cysteine rich domain (CRD) of

Frizzled (Fz), a 7-transmembrane protein of the GPCR family

(Bhanot, 1996)

.

The

palmitoleic acid group extends from the “thumb” region of the Wnt ligand into the
cysteine rich domain (CRD) of Fz, reinforcing the Wnt-Fz interaction
2009; Port, 2010; Herr, 2012; Clevers, 2012)

(Takada, 2006; Lorenowicz,

. A single Wnt can bind multiple Fz receptors and a single

Fz receptor can also bind multiple Wnt ligands

(Bhanot, 1996)

. Upon binding of Wnt ligand,

Fz forms receptor complexes with co-receptors, including low-density lipoprotein
receptor-related proteins 5/6 (LRP5/6), receptor Tyr kinase-like orphan receptors 1/2
(Ror1/2), and protein Tyr kinase 7 (PTK7) (Li, 2005; Grumolato, 2010; Peradziryi, 2012).
Wnt ligands also bind various agonists, such as the R-spondin family and Norrin,
and antagonists, such as Cerberus, Dickopf-related protein 1 (DKK1), secreted Frizzledrelated protein (SFRP), Wnt inhibitory factor (WIF), Sclerostin (and its homologue
Wise), which regulate Wnt signaling by affecting the assembly of ligand – receptor
complexes and/or the recruitment of co-receptors, or by affecting receptor endocytosis
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(Cruciat, 2012; Niehrs, 2012)

. Furthermore, Wnt ligands have since been found to also bind

alternate receptors independently of Fz through their interaction with a CRD and/or a
Wnt inhibitory factor (WIF) domain (Mikels, 2006). In this manner, Wnt ligands were found to
bind the CRDs of Ror and the muscle skeletal receptor Tyr kinase (MUSK), as well as
the WIF domain of the cell surface atypical receptor tyrosine kinase, receptor Tyr
kinase (Ryk).

These receptors may function as alternate receptors and/or Fz co-

receptors (Mikels, 2006). Specific combinations of Wnt ligands, receptors, co-receptors, and
cellular context induce various downstream signaling events which induce different
cellular responses. Depending on the induced downstream signaling events and the
cellular responses elicited, Wnt signaling is defined as either canonical or noncanonical. Generally speaking, canonical Wnt signaling involves binding of Wnt ligands
to Fz/LRP5/6, resulting in the stabilization and nuclear localization of the intracellular
effector, β-catenin, which in turn binds to T-cell/lymphoid enhancer factor (TCF/LEF)
transcription factors and activates transcription of canonical Wnt target genes. Noncanonical Wnt signaling, however, involves Wnt5a, Wnt11, or other Wnt ligands binding
to alternate Wnt receptors, such as Ryk, Ror, and MUSK, or to Fz, which recruits
alternate co-receptors, ultimately resulting in activation of distinct downstream
intracellular signaling events which may not involve stabilization and nuclear localization
of β-catenin. Accordingly, canonical Wnt signaling is commonly referred to as β-catenin
dependent Wnt signaling, while non-canonical Wnt signaling is commonly referred to as
β-catenin independent Wnt signaling.

Canonical Wnt signaling will be our focus

heretofore.
Canonical Wnt signaling is activated during embryonic development, as well as in
proliferating, migrating, and differentiating cells in adult tissues
Aman, 2008)

.

(Teo, 2010; Schambony, 2013;

Canonical Wnt signaling plays key roles in embryonic development,

contributing to processes of axis patterning, cell fate specification, cell polarity, cell
proliferation, and cell migration

(Peterson, 2009; Hikasa, 2013; Clevers, 2006a; van Amerongen, 2009)

.

Canonical Wnt is involved in gastrulation and body axis formation, including
specification of anteroposterior and dorsoventral axes
2009)

.

(van Amerongen, 2009; Hikasa, 2013; Peterson,

Canonical Wnt signaling induces mesoderm and endoderm during embryonic

development, and contributes to hematopoiesis

(Clevers, 2006a)

. At later stages, canonical
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Wnt signaling also contributes to the formation and maintenance of cartilage and bone,
heart, muscle, neurons of the peripheral and central nervous systems, skin, blood cells,
and other tissues

(Regard, 2012; Baron, 2013; Buikema, 2014; von Maltzahn, 2012; Patthey, 2008; Salinas, 2012; Lim,

2013; Lento, 2013)

. One example of the function of canonical Wnt signaling in development is

its involvement in the induction of neural crest cells, which migrate throughout the
embryo and differentiate, contributing to multiple tissues and organs including the
peripheral nervous system, the heart, and craniofacial bone and cartilage

(Elkouby, 2010; Wu,

2005; Le Douarin,1999)

. Dys-regulated Wnt signaling affects neural crest cell development,

and is implicated in developmental defects known as neurochristopathies, including
craniofacial and heart defects, as well as defects in neural development

(Etchevers, 2006;

Alexander, 2014; Veerle, 2008; Patthey, 2008)

.

Canonical Wnt signaling is also involved in stem cell maintenance and selfrenewal, tissue homeostasis, regeneration, and regulates insulin sensitivity in cells
(Clevers, 2014; Clevers, 2012; Palsgaard, 2012; Abiola, 2009)

. Aberrant Wnt signaling can result in various

forms of cancer, including colorectal cancer, gastrointestinal cancer, breast cancer, lung
cancer, glioblastoma, leukemia, melanoma, among others

(Clevers, 2012; Giles, 2003; Morin, 1997;

Logan, 2004; Reya, 2005; Bienz, 2000; de Lau, 2007; Schepers, 2012; Howe, 2004; Nguyen, 2009; Rheinbay, 2013; Damsky,
2011)

.

Aberrant Wnt signaling contributes to oncogenesis by promoting tumor cell

proliferation and metastasis

(Polakis, 2012; Clevers, 2012; Reya, 2005; Nguyen, 2009)

. Canonical Wnt

mutations that result in these cancers include mutations to β-catenin, mutations to APC
and other components of the β-catenin destruction complex, overexpression of Wnt
ligands, loss of inhibitors, and decreased activity of other signaling pathways that
regulate canonical Wnt signaling

(Morin, 1997; Polakis, 2012; Clevers, 2012; Reya, 2005; Logan, 2004)

. In

addition to developmental defects and its roles in carcinogenesis, dys-regulated Wnt
signaling is implicated in other pathologies including bone disease, and metabolic
diseases, such as Type II diabetes (Baron, 2013; Herr, 2012; Clevers, 2012).

1.1.2: Dual Roles of β-catenin: β-catenin Structure and Function
β-catenin is a key intracellular effector of canonical Wnt signaling that transduces
the signal to the nucleus, where β-catenin interacts with the TCF/LEF transcription
factors and activates transcription of Wnt/β-catenin target genes

(Cadigan, 2012)

. However,

4
non-canonical Wnt signaling, as mentioned earlier, is independent of β-catenin
.

Amerongen, 2012)

(van

In addition to its role in signaling, β-catenin plays a critical role in

stabilizing cell-cell adherens junctions by interacting with classical cadherins such as Ecadherin, a transmembrane protein, and linking it to cytoskeletal structures
2003)

.

(Conacci-Sorrell,

The recruitment and retention of β-catenin at adherens junctions through its

binding to the cytoplasmic tail of E-cadherin result in a pool of intracellular, membranebound β-catenin in the cell. Along with the negative regulatory activity of the β-catenin
destruction complex, a micro-environment that is restrictive of canonical Wnt signaling
emerges in cells participating in many cell-cell interactions and free of Wnt ligand
stimulation (i.e. cells that form tissues in vivo, and dense culture conditions in vitro).
This phenomenon results in a decrease in nuclear β-catenin levels and Wnt signaling
(Conacci-Sorrell, 2003)

. Due to this phenomenon, dense cell cultures have lower

activation

nuclear β-catenin and Wnt signaling activation than sparse cell cultures (Conacci-Sorrell, 2003).
The ability of β-catenin to participate in these diverse activities within the cell is
elucidated by its structure.
β-catenin, a member of armadillo multigene family, is a 90 kDa protein, and is
781 amino acids long (in humans), consisting of flexible N-terminal and C-terminal
domains (NTD, CTD) flanking a rigid central region made up of 12 Armadillo repeats
(Valenta, 2012)

. The CTD is linked to the central region by a conserved helix, Helix-C

(Xing,

. The various interaction partners of β-catenin bind to the long, positively charged

2008)

groove of the Armadillo repeats by forming salt bridges with Lys312 and Lys435

(Valenta,

2012)

. Only one of these interaction partners, including E-cadherin, adenoma polyposis

coli (APC), and TCF/LEF, can bind to β-catenin at a time, creating competition for βcatenin and regulating the function of β-catenin based on its availability and subcellular
localization (Figure 1)

(Krieghoff, 2006; Valenta, 2012; Morgan, 2014)

. Accordingly, maintenance of

different pools of β-catenin within the cell and post-translational modifications control the
spatial separation, retention, and stability of β-catenin, contributing to its dual role as a
signaling molecule and structural protein (Valenta, 2012; Morgan, 2014).
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Figure 1: β-catenin ARM Domain Interactors. E-cadherin, Axin, APC, and the
TCF/LEF transcription factors are known to interact with the ARM domain of β-catenin.
Only one of these interaction partners, including E-cadherin, adenoma polyposis coli
(APC), and TCF/LEF, can bind to β-catenin at a time, creating competition for β-catenin
and regulating the function of β-catenin based on its availability and subcellular
localization (Image reprinted with permission from Creative Commons: Image by
Bubus12 (Own work) [CC BY 3.0 license], via Wikimedia Commons).
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1.1.3: Regulation of β-catenin Stability
The balance between sequestration of β-catenin by cadherins at adherens
junctions and canonical Wnt signaling activity affects the levels of cytoplasmic β-catenin
. In the absence of Wnt signaling, cytoplasmic β-catenin is

(Conacci-Sorrell, 2003; Valenta, 2012)

phosphorylated and ubiquitinated, marking it for degradation via the 26S proteasome by
a multi-protein destruction complex that resides in the cytoplasm known as the βcatenin destruction complex. The β-catenin destruction complex, hereafter referred to
solely as the destruction complex, consists of Dishevlled (Dvl), the scaffold proteins
Axin and APC, the kinases glycogen synthase kinase 3 β (GSK3β) and casein kinase 1
α (CK1α), the phosphatase protein phosphatase 2A (PP2A), and the E3 ubiquitin ligase
F-box protein β-transducin repeat containing protein (β-TrCP)

(Li, 2012b; Stamos, 2013; Valenta,

. Cytoplasmic β-catenin binds to APC and Axin, which recruit β-catenin to

2012; Clevers, 2012)

the destruction complex

(Li 2012; Clevers, 2012; Stamos 2013)

. These interactions bring β-catenin

in close proximity of CK1α and GSK3β, allowing their sequential phosphorylation of βcatenin

. CK1α phosphorylates β-catenin at Ser45, which

(Liu 2002; Zeng, 2005; Verheyen, 2010)

primes β-catenin for the subsequent sequential phosphorylation of Thr41, Ser37, and
Ser33 by GSK3β

. Phosphorylation of β-catenin by GSK3β

(Liu 2002; Zeng, 2005; Verheyen, 2010)

is dependent upon interaction of GSK3β with Axin and APC

(Valenta, 2012)

.

These

phosphorylation events result in the formation of the DSGXXS degron motif at the Nterminal domain of β-catenin, which is recognized by the F-box protein β-transducin
repeat containing protein (β-TrCP)

(Lau, 2012; Clevers, 2012; Valenta, 2012)

. APC protects the

phosphorylated DSGXXS degron from dephosphorylation by PP2A

(Su, 2008)

. Binding of

β-TrCP associates β-catenin with the E3 ubiquitin ligase complex, Skp1/Cul1/F-box/ βTrCP (SCF

β-TrCP

), resulting in the ubiquitination of β-catenin and its subsequent

degradation by the 26S proteasome

(Hart, 1999; Latres,1999; Li 2012; Stamos 2013; Valenta, 2012)

. The

degradation of cytoplasmic β-catenin by the destruction complex prevents cytoplasmic
accumulation of β-catenin, thereby preventing the translocation of β-catenin to the
nucleus and the initiation of transcription of Wnt target genes

(Li, 2012b; Clevers, 2012; Stamos,

. In addition to degradation of cytoplasmic β-catenin, transcription of

2013; Valenta, 2012)

Wnt/β-catenin target genes are further repressed by epigenetic events in the absence of
Wnt signaling. The co-repressor Groucho binds to TCF/LEF transcription factors in the
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absence of Wnt signaling, and along with other epigenetic factors, inhibits the
transcription of Wnt target genes (Roose, 1998; Daniels, 2005; Clevers, 2012; Valenta, 2012).
Binding of Wnt ligands to Fz and LRP5/6 results in inhibition of the β-catenin
destruction complex

(Valenta, 2012)

.

In the presence of canonical Wnt ligand, Fz and
(Valenta, 2012; Clevers, 2012)

LRP5/6 form a heterodimeric receptor complex

. The cytoplasmic

tail of Fz interacts with Dvl, and the DIX domain of the associated Dvl is exposed upon
binding of Wnt to Fz

(Chen, 2003; Valenta, 2012)

. Axin binds to the exposed DIX domain,

recruiting the associated destruction complex components to the receptor complex
(Schwarz-Romond, 2007; Fiedler, 2011; Clevers, 2012; Valenta, 2012)

. This brings CK1γ/ε of the destruction

complex into proximity of LRP5/6, allowing CK1γ/ε to phosphorylate LRP5/6, which
blocks GSK3β activity (Liu, 2002; Zeng, 2005; Valenta, 2012). This Wnt – induced inhibition of the βcatenin destruction complex results in the stabilization of β-catenin in the cytoplasm,
allowing β-catenin to translocate to the nucleus and initiate transcription of Wnt target
genes by displacing the co-repressor Groucho and binding to TCF/LEF transcription
factors, and recruiting other transcriptional co-activators and histone modifiers including
Brg1, CBP/p300, Cdc47, Bcl9, and Pygopus

(Li, 2012a; Clevers, 2012; Roose, 1998; Daniels, 2005;

Mosimann, 2009; Hecht, 2000; Takemaru, 2000; Li, 2007; Brack, 2009; Schwab, 2007)

. The mechanisms by which

β-catenin is transported into and out of the nucleus are not completely clear
Morgan, 2014; Valenta, 2012)

.

(Krieghoff, 2006;
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Figure 2: Canonical Wnt Signaling. (Left) In the absence of Wnt ligand, LRP5/6 is
not phosphorylated, and the destruction complex, consisting of Dvl, Axin, GSK3-β, APC,
and β-TrCP, resides in the cytoplasm where it binds, phosphorylates, and ubiquitinates
β-catenin, marking β-catenin for degradation by the proteasome. (Right) Wnt ligands
secreted from nearby cells bind to the Fz receptor, inducing the recruitment of the coreceptors LRP5/6. The assembly of this receptor complex triggers the association of
the destruction complex with phosphorylated LRP. The association of the destruction
complex with the Wnt/Fz/Lrp5/6 receptor complex blocks the phosphorylation of βcatenin by GSK3β, thus preventing recognition of β-catenin by β-TrCP and the
subsequent degradation of β-catenin by the proteasome. The net effect of these
interactions is the stabilization of β-catenin in the cytoplasm, which allows β-catenin to
enter the nucleus where it binds TCF/LEF transcription factors and regulates the
transcription of canonical Wnt target genes (Image reprinted with permission from
InTechOpen: Image Copyright © 2013 Inestrosa, N.C., Varela-Nallar, L. Published in
[Wislet, 2013] under CC BY 3.0 license).
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Figure 3: Wnt Signaling in the Nucleus. In the absence of Wnt signals, the corepressor Groucho binds to TCF and represses its target genes. Following the
activation of Wnt signaling and the subsequent stabilization of β-catenin in the
cytoplasm, β-catenin migrates into the nucleus where it replaces Groucho from
TCF/LEF and recruits transcriptional coactivators and histone modifiers such as Brg1,
CBP, Cdc47, Bcl9, and Pygopus to drive the expression of canonical Wnt target genes
(Image reprinted with permission from Elsevier Inc: Cell [Clevers, 2012] Copyright ©
2012 Elsevier Inc).
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1.1.4: β-catenin Subcellular Localization
Although it is widely accepted that cytoplasmic accumulation of β-catenin
precludes nuclear translocation of β-catenin, the mechanism by which β-catenin is
transported into and out of the nucleus is unclear

(Valenta, 2012)

. While proteins less than

30 kDA are readily diffusible through the nuclear pores, proteins larger than 50 kDA, like
β-catenin (90 kDA), require active transport via the nuclear receptor dependent
(importin/exportin) pathways through the nuclear pore complex (NPC)

(Morgan, 2014)

.

Interestingly, β-catenin does not have a recognizable nuclear localization signal (NLS)
or nuclear export signal (NES) necessary for transport through nuclear receptor
dependent pathways, and does not require Ran-GTPase for transport

(Eleftheriou, 2001;

Fagotto, 1998; Wiechens, 2001; Yokoya, 1999)

. Several proteins have been implicated in mediating

nuclear import of β-catenin through the nuclear receptor dependent import pathway
(importin α:β) by acting as chaperones, including adenomatous polyposis coli (APC),
Ras-related C3 botulinum toxin substrate 1 (Rac1), Smad3/4, forkhead box M1
(FoxM1), insulin receptor substrate 1 (IRS1), cell surface associated mucin 1 (MUC1),
B-cell CLL/lymphoma 9 (BCL-9), and the androgen receptor

(Henderson, 2000; Wang, 2014; Wu,

2008; Jian, 2006; Li, 2006; Zhang, 2010; Zhang, 2011; Chen, 2005; Li, 2011; Wen, 2003; Brembeck, 2004; Krieghoff, 2006;
Mulholland, 2002; Pawlowsk, 2002)

.

In addition, the TCF/LEF transcription factors that are activated by β-catenin in
the nucleus have also been proposed to chaperone β-catenin into the nucleus through a
nuclear receptor-dependent pathway

(Krieghoff, 2006; Molenaar, 1996; Behrens, 1996; Huber, 1996; Simcha,

. Similarly, several proteins have been implicated in mediating nuclear export of β-

1998)

catenin through the nuclear receptor dependent export pathway by binding
chromosome maintenance region 1 (CRM1) and acting as chaperones, including APC,
Axin, Chibby, menin, leucine zipper tumor suppressor 2 (LZTS2), p21-activated kinase
4 (PAK4), and Kank

(Henderson, 2000; Krieghoff, 2006; Neufeld, 2000a; Neufeld, 2000b; Rosin-Arbesfeld, 2003; Wang,

2014; Cong, 2004; Wiechens, 2004; Li, 2008; Li, 2010; Cao, 2009; Thyssen, 2006; Li, 2012a; Wang, 2006)

.

In contrast to chaperone-mediated transport of β-catenin through nuclear
receptor dependent pathways, it has been demonstrated that β-catenin can be
transported into and out of the nucleus through chaperone- and nuclear receptor-
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independent pathways

(Eleftheriou, 2001; Fagotto, 1998; Wiechens, 2001; Yokoya, 1999)

. The armadillo

repeat sequences 10-12 (R10-12) of β-catenin directly bind phenylalanine-glycine FxFG
or GLFFG repeats (FG repeats) of nucleoporins Nup62, Nup98, Nup153, and
RanBP2/Nup358, facilitating transport of β-catenin through the NPC

(Sharma, 2012)

. Since

the interaction partners of β-catenin generally bind armadillo repeat sequences 3-8 (R38), R10-12 remain accessible, raising the possibility that β-catenin may shuttle its
interaction partners into and out of the nucleus through these nuclear receptor and RanGTPase independent mechanisms (Sharma, 2012). Consistent with these mechanisms of βcatenin transport, the subcellular localization of β-catenin may be controlled by retention
through the relative abundance of β-catenin binding partners in the nucleus, cytoplasm,
and at the cell membrane (Li, 2012a; Krieghoff, 2006; Morgan, 2014; Valenta, 2012).
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1.2: Ephrin Signaling
1.2.1: Ephrin Signaling
Wei et al. have previously identified a novel crosstalk between canonical Wnt
signaling and ephrin signaling, which likely involves alteration of the stability of βcatenin, and/or the sub-cellular localization of β-catenin

(Wei, 2010)

.

Ephrin signaling

occurs through the interaction of ephrin ligands and Eph receptor tyrosine kinases, and
can be unidirectional (forward or reverse) or bidirectional (forward and reverse
(Pasquale, 2010)

simultaneously), depending on the directions of signal flow

.

Forward

signaling occurs when the signal is transduced from the ephrin ligand-expressing cell
into the Eph receptor-expressing cell, while reverse signaling occurs in the opposite
direction, simultaneously activating molecular pathways downstream of ephrins and
Ephs

(Pasquale, 2010)

.

Bidirectional signaling occurs when both forward and reverse

signaling occur simultaneously via the same Eph/ephrin interaction

(Pasquale, 2010)

.

Transmembrane Eph receptors exclusively bind membrane-tethered ephrin ligands, and
therefore, ephrin signaling requires cell-cell contact

(Klein, 2012)

.

classes of Eph receptors, including EphA and EphB

There are two sub-

(Klein, 2012)

.

In general, EphA

receptors bind glycosylphosphotidylinositol (GPI)-linked ephrin-A ligands, while EphB
receptors bind transmembrane ephrin-B ligands, however, there are some Eph
receptors that can bind both ligand subclasses (Pasquale, 2008; Klein, 2012).
Ephrin ligands and Eph receptors interact in trans, inducing the formation of
Eph/ephrin heterodimers

(Klein,

2012)

.

These heterodimers bind to other Eph/ephrin

heterodimers, forming heterotetramers, which assemble into higher-order clusters through the
recruitment of other ligand-bound Eph receptors

(Klein, 2012)

.

These higher-order clusters are

required for forward and reverse ephrin signaling, and the strength of the forward and reverse
signals increases with the recruitment of additional ligand-bound receptors

(Klein, 2012; Kania, 2016)

.

Interestingly, Eph receptor clusters can laterally recruit additional Eph receptors independent of
ephrins

(Klein, 2012)

. Within the clusters of Eph/ephrins, different sets of the Eph/ephrins

may participate in forward and/or reverse signaling simultaneously, resulting in the
phenomena of parallel and anti-parallel signaling

(Kania, 2016)

. Parallel signaling occurs

when two or more adjacent Eph/ephrins signal simultaneously in the same direction
(forward or reverse) (Kania, 2016). Anti-parallel signaling occurs when two or more adjacent
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Eph/ephrins signal simultaneously in opposite directions (Kania, 2016). In addition, ephrin-A
ligands can interact in cis with co-receptors

(Klein, 2012)

. Eph/ephrins can interact with

other ligand/receptor systems, integrating environmental signals and disparate signaling
events, producing diverse outcomes in terms of development and tissue homeostasis,
maintenance, and function.
Eph receptors have a highly conserved domain organization, consisting of a
globular ligand binding domain (LBD), a cysteine rich region that includes a Sushi and
an epidermal growth factor (EGF)-like domain, two fibronectin type III domains (FN1
and FN2), a transmembrane (TM) helix, an intracellular juxtamembrane (JM) region that
features several conserved tyrosine (Y) residues, a tyrosine kinase domain (TK), a
sterile-α motif (SAM) protein-protein interaction domain, and a C-terminal Psd-95, Dlg,
and Z01 domain (PDZ)-binding motif

(Pasquale, 2008; Klein, 2012)

.

Ephrin-A and ephrin-B

ligands possess an extracellular receptor-binding domain (RBD)

(Klein, 2012)

. Ephrin-A

ligands are GPI-anchored, while ephrin-B ligands have a TM helix, an intracellular
region with several conserved tyrosine residues and a C-terminal PDZ-binding motif
(Klein, 2012)

.

The JM region of Eph receptors suppresses the intrinsic Eph kinase activity
through auto-inhibition due to its inactive conformation

(Wybenga-Groot, 2001)

. Activation of

Eph receptors results in phosphorylation of tyrosine residues (P) of the JM domain,
which relieves the auto-inhibition

(Klein, 2012)

.

The kinase domain adopts an active

conformation, resulting in phosphorylation of the TK and SAM domains and initiation of
downstream signaling events through phosphorylation of intracellular effectors (Klein, 2012).
In addition, the tyrosine residues of the intracellular region of ephrin-Bs are
phosphorylated in response to binding with Eph receptors (Kullander, 2002).
Forward ephrin signaling activates intrinsic tyrosine kinase activity of the Eph
receptors, regulating the recruitment and activity of intracellular effector proteins such
as non-catalytic region of tyrosine kinase adaptor protein 1 (Nck1) and Nck2 (also
known as Grb4), phosphoinositide 3-kinase (PI3K), Vav2 and Vav3, Src, α2-chimerin,
and ephexins

(Klein, 2012; Kania, 2016)

. These effectors are coupled to Ras homology (Rho)

subfamily of Ras-like small GTP-ases, including Ras-related C3 botulinum toxin
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substrate 1 (Rac1), cell division control protein 42 homolog (Cdc42), and RhoA (Klein, 2012;
Kania, 2016)

. By regulating the activity of Src family kinases and Ras/Rho family GTP-ases,

ephrin signaling affects cytoskeletal dynamics (Klein, 2012; Kania, 2016).
These events lead to the recruitment of PDZ domain-containing proteins, and
possibly other effectors, such as the SH2/SH3 adaptor Grb4, p21 protein (Cdc42/Rac)activated kinase 1 (Pak1), and dedicator of cytokinesis 1 (Dock180), which then elicit
cellular responses. Reelin can also bind to ephrin-B1 and ephrin-B3, leading to the
activation of disabled 1 (Dab1), which elicits cellular responses.
The mechanism of reverse ephrin-B signaling is not well understood, but one
mechanism involves recruitment of Src family kinases and tyrosine phosphorylation of
its intracellular domain (Xu, 2002; Klein, 2012; Kania, 2016). These events lead to the recruitment
of PDZ domain-containing proteins, and possibly other effectors, such as the SH2/SH3
adaptor Grb4, p21 protein (Cdc42/Rac)-activated kinase 1 (Pak1), and dedicator of
cytokinesis 1 (Dock180), which then elicit cellular responses (Xu, 2002; Klein, 2012; Kania, 2016).
Reelin can also bind to ephrin-B1 and ephrin-B3, leading to the activation of disabled 1
(Dab1), which elicits cellular responses

(Kania, 2016)

. Although ephrin-A ligands lack an

intracellular region, and therefore are not phosphorylated intracellularly, they also
participate in reverse signaling by coupling to co-receptors, such as the Src family
tyrosine kinase, Fyn, and the receptor tyrosine kinase, Ret, which elicit cellular
responses (Klein, 2012; Kania, 2016).
Termination of Eph/ephrin signaling is achieved by ectodomain cleavage or
endocytosis. When co-expressed in the same cell, A distintegrin and metalloprotease
domain (ADAM)-type proteases cleave ephrin-A and ephrin-B proteins in cis

(Hattori, 2000)

.

When expressed in an adjacent, opposing cell, ADAM-type proteases cleave ephrin-A
and ephrin-B proteins in trans

(Janes, 2005)

metalloproteases and γ-secretase

. In addition, Eph receptors are cleaved by

(Bai, 2011)

.

Endocytosis of complete Eph/ephrin

complexes from the cell membrane can also achieve termination of Eph/ephrin signaling
(Klein, 2012)

. Ephrin-B can be trans-endocytosed into the EphB-expressing cell and EphB

can be trans-endocytosed into the ephrin-B-expressing cell

(Klein, 2012)

.

The balance

between uni- and bi-directional endocytosis may depend on cellular context, may result
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in unique downstream signaling events, and contributes to the various functions of
Eph/ephrins (Marston, 2003; Zimmer, 2003; Pitulescu, 2010; Klein, 2012).
Ephrin signaling affects cytoskeletal dynamics, driving changes in cell shape and
cell-cell contacts
contributes

to

(Klein, 2012; Kania, 2016)

.

cell-cell

Through these mechanisms, ephrin signaling

repulsion/adhesion,

proliferation, and axon guidance

segregation,

positioning,

migration,

(Klein, 2012; Kania, 2016)

. These cellular responses underlie

the roles of ephrin signaling in development, such as patterning, morphogenesis, and
tissue boundary formation. These cellular responses also underlie the roles of ephrin
signaling in tissue homeostasis, maintenance, and function in adult tissues

(Klein, 2012;

Kania, 2016)

. Due to these critical roles of ephrin signaling, aberrant ephrin signaling is

implicated in developmental defects and diseases including neuronal defects, bone
remodeling diseases, diabetes, and cancer (Pasquale, 2008; Klein, 2012; Pasquale, 2010).
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Figure 4:
Eph/ephrin Domain Organization and Signaling Modes.
a) Transmembrane Eph receptor tyrosine kinases bind membrane-tethered ephrin
ligands in trans, and therefore, ephrin signaling requires cell-cell contact. Ephrin
signaling affects cytoskeletal dynamics, driving changes in cell shape and cell-cell
contacts.
Through these mechanisms, ephrin signaling contributes to cell-cell
repulsion/adhesion, segregation, positioning, migration, proliferation, and axon
guidance.
These cellular responses underlie the roles of ephrin signaling in
development, such as patterning, morphogenesis, and tissue boundary formation, as
well as the roles of ephrin signaling in tissue homeostasis, maintenance, and function in
adult tissues. b) Eph receptors (left) have a highly conserved domain organization,
consisting of a globular ligand binding domain (LBD), a cysteine rich region that
includes a Sushi and an epidermal growth factor (EGF)-like domain, two fibronectin type
III domains (FN1 and FN2), a transmembrane (TM) helix, an intracellular
juxtamembrane (JM) region that features several conserved tyrosine (Y) residues, a
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tyrosine kinase domain (TK), a sterile-α motif (SAM) protein-protein interaction domain,
and a C-terminal Psd-95, Dlg, and Z01 domain (PDZ)-binding motif. Ephrin-A and
ephrin-B ligands possess an extracellular receptor-binding domain (RBD). Ephrins
(right) are divided into A and B classes based on their affinity for EphA or EphB
receptors and whether they are tethered to the membrane via a
glycosylphosphatidylinositol GPI linkage (class A), or as type-I transmembrane proteins
(class B). Unlike the GPI-anchored ephrin-A ligands, ephrin-B ligands have a TM helix,
an intracellular region with several conserved tyrosine residues and a C-terminal PDZbinding motif. The JM region of Eph receptors suppresses the intrinsic Eph kinase
activity through auto-inhibition due to its inactive conformation. Activation of Eph
receptors results in phosphorylation of tyrosine residues (P) of the JM domain, which
relieves the auto-inhibition. The kinase domain adopts an active conformation, resulting
in phosphorylation of the TK and SAM domains and initiation of downstream signaling
events through phosphorylation of intracellular effectors. Phosphorylation of the
tyrosine residues of the intracellular domains of ephrin-B ligands also occurs in
response to Eph-ephrin interaction, and is involved in reverse signaling. In addition, the
tyrosine residues of the intracellular region of ephrin-Bs are phosphorylated in response
to binding with Eph receptors. c) Ephrin signaling can be unidirectional (forward or
reverse) or bidirectional (forward and reverse simultaneously), depending on the
direction(s) of signal flow. Arrows indicate signaling events, and X’s indicate the
absence of signaling. Forward signaling occurs when the signal is transduced from the
ephrin ligand-expressing cell into the Eph receptor-expressing cell, while reverse
signaling occurs in the opposite direction. Bidirectional signaling occurs when both
forward and reverse signaling occur simultaneously via the same Eph/ephrin interaction,
simultaneously activating molecular pathways downstream of ephrins and Ephs.
Because there may be multiple Eph/ephrin (A and/or B) and/or ephrin/Eph (A and/or B)
interactions occurring simultaneously at the junctions between two cells, the
phenomena of parallel and anti-parallel signaling emerge. Parallel signaling occurs
when two or more Eph/ephrins signal simultaneously in the same direction (forward or
reverse), propagating forward or reverse signals in the same direction. Anti-parallel
signaling occurs when two or more Eph/ephrins signal simultaneously in opposite
directions, simultaneously propagating forward signals in one direction and reverse
signals in the opposite direction (Image reprinted with permission from Macmillan
Publishers Ltd: Nature Reviews Molecular Cell Biology [Kania, 2016], Copyright ©
2016).
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Figure 5: Eph/ephrin Complexes and Receptor Clustering, and Downstream
Molecular Pathways and Cellular Responses. a) Ephrin ligands and Eph receptors
interact in trans, inducing the formation of Eph/ephrin heterodimers.
These
heterodimers bind to other Eph/ephrin heterodimers, forming heterotetramers, which
assemble into higher-order clusters through the recruitment of other ligand-bound Eph
receptors. These higher-order clusters are required for forward and reverse ephrin
signaling, and the strength of the forward and reverse signals increases with the
recruitment of additional ligand-bound receptors. Interestingly, Eph receptor clusters
can laterally recruit additional Eph receptors independent of ephrins. The tyrosine
phosphorylation events (P), as described in Figure 4, are also shown. b) Crystal
structure of a higher-order cluster of an ephrin-A5-EphA2 complex. c) Schematic
representations of downstream molecular pathways activated downstream of forward
ephrin signaling that affect cytoskeletal changes underlying various cellular responses.
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Forward ephrin signaling activates intrinsic tyrosine kinase activity of the Eph receptors,
regulating the recruitment and activity of intracellular effector proteins such as noncatalytic region of tyrosine kinase adaptor protein 1 (Nck1) and Nck2 (also known as
Grb4), phosphoinositide 3-kinase (PI3K), Vav2 and Vav3, Src, α2-chimerin, and
ephexins. These effectors are coupled to Ras homology (Rho) subfamily of Ras-like
small GTP-ases, including Ras-related C3 botulinum toxin substrate 1 (Rac1), cell
division control protein 42 homolog (Cdc42), and RhoA. By regulating the activity of Src
family kinases and Ras/Rho family GTP-ases, ephrin signaling affects cytoskeletal
dynamics. d) The mechanism of reverse ephrin-B signaling is not well understood, but
one mechanism involves recruitment of Src family kinases and tyrosine phosphorylation
of its intracellular domain. These events lead to the recruitment of PDZ domaincontaining proteins, and possibly other effectors, such as the SH2/SH3 adaptor Grb4,
p21 protein (Cdc42/Rac)-activated kinase 1 (Pak1), and dedicator of cytokinesis 1
(Dock180), which then elicit cellular responses. Reelin can also bind to ephrin-B1 and
ephrin-B3, leading to the activation of disabled 1 (Dab1), which elicits cellular
responses. Although ephrin-A ligands lack an intracellular region, and therefore are not
phosphorylated intracellularly, they also participate in reverse signaling by coupling to
co-receptors, such as the Src family tyrosine kinase, Fyn, and the receptor tyrosine
kinase, Ret, which elicit cellular responses (Image reprinted with permission from
Macmillan Publishers Ltd: Nature Reviews Molecular Cell Biology [Kania, 2016],
Copyright © 2016).

20

1.3: Canonical Wnt – ephrin-B Crosstalk
1.3.1: Evidence of Canonical Wnt – ephrin-B Crosstalk
Wnt signaling and ephrin-B signaling are both involved in regulation of the
(Clevers,

intestinal stem cell niche, and the normal tissue homeostasis of the intestine
2006b)

.

The small intestine contains protrusion known as villi, and the basal areas

between these villi are known as crypts. The cells in the intestinal crypts are stem cells
and Paneth cells, which express EphB receptors (EphB2, EphB3, and EphB4)

(Clevers,

2006b; Kania, 2016)

. As these cells differentiate, they proliferate and migrate up the villi from

the intestinal crypt and come into contact with the differentiated cells at the apical
portion of the villi, which express ephrin-B1 and ephrin-B2

(Clevers, 2006b; Kania, 2016)

. Cell-

cell contact and the initiation of EphB/ephrin-B signaling between the ephrin-B1/B2
expressing cells and the migrating EphB cells from the crypt leads to the loss of EphB
expression in these cells, allowing for their differentiation and normal tissue
homeostasis

(Clevers, 2006b; Kania, 2016)

. These events result in the formation of a gradient of

EphB expression that is strongest at the base of the crypts and weakest at the apical
portion of the villi, and an opposing ephrin-B gradient that is strongest at the apical
portion of the villi and weakest at the base of the crypts

(Clevers, 2006b; Kania, 2016)

. Loss of

ephrin-B signaling disrupts cell proliferation and positioning along the villus – crypt axis
(Kania, 2016)

.

Mutations in the tumor suppressor gene APC (APCmut) leads to the

constitutive activation of canonical Wnt signaling, and the transformation of these cells
into tumor-initiating cells (cells inside the box labeled APCmut)

(Clevers, 2006b)

.

These

proliferate and migrate up the crypt, accumulating at the villi and forming benign polylike outgrowths, or adenomas

(Clevers, 2006b)

. These tumor-initiating cells express high

levels of EphB receptors, and contact of these cells with normal differentiated cells
expressing high levels of ephrin-B ligands at the apical portion of the villi results in
activation of ephrin-B signaling

(Clevers, 2006b)

. EphB repulsive signals limit the spread of

the tumor. These findings illustrate how the orchestration of canonical Wnt and ephrin
signaling programs can contribute to normal development and tissue homeostasis, and
disruption of these signaling gradients can result in colorectal cancer.
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Direct inhibition of Wnt signaling by ephrin-B signaling was suggested by the
finding that the metalloprotease ADAM13 cleaves ephrin-B1, permitting canonical Wnt
signaling during cranial neural crest (CNC) induction in Xenopus tropicalis embryos

(Wei,

2010)

. Furthermore, wild-type Xenopus ephrin-B1 (ephrin-B1WT) and ephrin-B1ΔC (a

mutant ligand that lacks the cytoplasmic tail and hence only promotes forward, but not
reverse, ephrin signaling) inhibit Wnt reporter (TOP/FOP FLASH) expression when Wnt
signaling is activated by Wnt8 in Xenopus tropicalis embryos and by Wnt3a in human
embryonic kidney (HEK293T) cells (Wei, 2010).
It has been shown previously that decreased nuclear β-catenin is a consequence
of increased ephrin signaling through Eph receptors during carcinogenesis

(Chiu, 2009)

.

Taken together, these data indicate a novel crosstalk between Wnt and ephrin signaling
axes in which ephrin-B signaling antagonizes canonical Wnt signaling. The molecular
mechanism that mediates this antagonistic interaction is unknown. Furthermore, this
antagonistic interaction provides a unique system in which to investigate the
mechanisms of inhibition of canonical Wnt signaling. Canonical Wnt signaling can be
modulated through interactions at various levels of the canonical Wnt signaling axis
including 1) ligand – receptor and receptor – receptor interactions, 2) β-catenin stability,
3) β-catenin localization, and 4) β-catenin/TCF/LEF/DNA interactions (Figure 8).
Therefore, we aimed to gain insight into the mechanisms of ephrin-B antagonism of
canonical Wnt signaling by differentiating among these possibilities.
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Figure 6: Canonical Wnt and Eph/ephrin Interactions in the Intestinal Stem Cell
Niche and Colorectal Cancer Progression. The small intestine contains protrusion
known villi, and the basal areas between these villi are known as crypts. 1) The cells in
the intestinal crypts are stem cells and Paneth cells, which express EphB receptors
(EphB2, EphB3, and EphB4). As these cells differentiate, they proliferate and migrate
up the villi from the intestinal crypt and come into contact with the differentiated cells at
the apical portion of the villi, which express ephrin-B1 and ephrin-B2. Cell-cell contact
and the initiation of EphB/ephrin-B signaling between the ephrin-B1/B2 expressing cells
and the migrating EphB cells from the crypt leads to the loss of EphB expression in
these cells, allowing for their differentiation and normal tissue homeostasis. These
events result in the formation of a gradient of EphB expression that is strongest at the
base of the crypts and weakest at the apical portion of the villi, and an opposing ephrinB gradient that is strongest at the apical portion of the villi and weakest at the base of
the crypts. Loss of ephrin-B signaling disrupts cell proliferation and positioning along
the villus – crypt axis. 2) Mutations in the tumor suppressor gene APC (APCmut) leads
to the constitutive activation of canonical Wnt signaling, and the transformation of these
cells into tumor-initiating cells (cells inside the box labeled APCmut). These proliferate
and migrate up the crypt, accumulating at the villi and forming benign poly-like
outgrowths, or adenomas. 3) These tumor-initiating cells express high levels of EphB
receptors, and contact of these cells with normal differentiated cells expressing high
levels of ephrin-B ligands at the apical portion of the villi results in activation of ephrin-B
signaling. 4) EphB repulsive signals limit the spread of the tumor (Image reprinted with
permission from Eduard Battle Lab, IRB Barcelona [Batlle, 2007]).

23

Figure 7: Wild-type ephrin-B and ephrin-B1ΔC Inhibit Wnt3a – Induced Reporter
Activity. HEK293T cells were transfected with pTOP FLASH (TOP) and pFOP FLASH
(FOP) and the indicated constructs and cultured for ~40 hours. Cell lysates were
processed for luciferase assays. A representative experiment performed in triplicate is
shown here. Results are presented as average ratios of TOP vs. FOP luciferase
activity, and the error bars represent standard deviations. *: P < 0.05, **: P < 0.01, *** P
< 0.001 (Image reprinted with permission from Elsevier Inc: Developmental Cell [Wei,
2010; supplement] Copyright © 2010 Elsevier Inc).
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Figure 8: Regulation of the Wnt Signaling Axis. Canonical Wnt signaling can be
modulated through interactions at various levels of the canonical Wnt signaling axis
including 1) ligand – receptor and receptor – receptor interactions, 2) β-catenin stability,
3) β-catenin localization, and 4) β-catenin/TCF/LEF/DNA interactions (Image adapted
with permission from InTechOpen: Image Copyright © 2013 Inestrosa, N.C., VarelaNallar, L. Published in [Wislet, 2013] under CC BY 3.0 license).
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1.3.2: Regulators of β-catenin Stability and Localization
β-catenin levels and β-catenin subcellular localization are affected by interactions
with protein modifiers within the cell, and other cellular signaling pathways. β-catenin is
modified by GSK3β and c-Jun N-terminal kinase 1 and 2 (JNK1, JNK2), and
adenomatous polyposis coli (APC) and Ras-related C3 botulinum toxin substrate 1
(Rac1) affect β-catenin subcellular localization

(Liu, 2002; Zeng, 2005; Hu, 2008; Hu, 2009; Henderson,

. In addition, classical cadherins, such as E-cadherin, sequester β-

2000; Wang, 2014; Wu, 2008)

catenin to the cell membrane through the binding of β-catenin to the cytoplasmic tail of
E-cadherin, resulting in a decrease in nuclear β-catenin and Wnt signaling activation
. Therefore, dense cell cultures have lower nuclear β-catenin and Wnt

(Conacci-Sorrell, 2003)

signaling activation than sparse cell cultures

. These effectors of β-

(Conacci-Sorrell, 2003)

catenin stability and β-catenin subcellular localization represent potential nexuses
through which ephrin-B signaling may interact with Wnt signaling.

1.3.3: c-Jun N-terminal kinase 1 and 2 (JNK1, JNK2)
One intriguing possible mediator of the ephrin-B induced antagonism of
canonical Wnt signaling is JNK. JNK is a downstream target of forward ephrin signaling
and can prevent nuclear β-catenin accumulation

(Stein, 1998; Liao, 2006)

. In addition, it has

previously been demonstrated that JNK1 and JNK2 can affect the stability, amount and
subcellular localization of β-catenin

(Hu, 2008; Hu, 2009; Wu, 2008)

. JNK1 and JNK2 cause a

reduction in β-catenin in HEK293T cells, with JNK2 causing a greater reduction in βcatenin than JNK1, and this reduction in β-catenin occurs through the ubiquitinproteasome system (UPS) and is mediated by GSKβ

(Hu, 2008; Hu, 2009)

. Furthermore,

preliminary data from Laura Christian, a former post-doc in the Wei lab, indicates that
co-transfection of ephrin-B1ΔC and EphB2 in HeLa cells results in an increase in JNK
activity (Figure 9)
antagonizes

(Christian et al., unpublished)

canonical

. Therefore, we propose that ephrin-B signaling

Wnt

signaling

by

activating

JNK,

preventing

nuclear

accumulation of β-catenin and inducing degradation of β-catenin via the UPS mediated
by GSKβ.
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Figure 9: Ephrin-B Signaling Activates c-Jun N-terminal kinase (JNK). HeLa cells
were transfected to express the indicated proteins, and in vitro JNK activity assays were
carried out using a JNK Kinase Assay Kit (Cell Signaling Technology; 8794). JNK was
pulled down from cell lysates by using an α JNK antibody, and incubated with
recombinant c-Jun protein. Western blot was performed by using an α phospho-c-Jun
antibody (Data courtesy of Dr. Laura Christian et al., unpublished).
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Figure 10: Proposed Models for JNK-mediated ephrin-B Antagonism of Canonical
Wnt Signaling. (Model A) Forward ephrin-B signaling results in intracellular activation
of Dvl. Dvl activates downstream signaling events and initiates PCP signaling, which
inhibits canonical Wnt signaling. (Model B) Forward ephrin-B signaling results in
downstream activation of JNK. JNK interacts with and modifies β-catenin, triggering
nuclear export of β-catenin.
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Chapter 2: Specific Aims
2.1: Specific Aims
1) To test if the ephrin-B antagonism of canonical Wnt signaling first described in
Xenopus laevis is conserved in mammals.
2) To determine the cellular processes that mediate this crosstalk by investigating
the effects of ephrin-B signaling on the 2a) stabilization and 2b) subcellular
localization of β-catenin.
3) To determine how downstream effectors of ephrin-B signaling may interact with
β-catenin, mediating this crosstalk.
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2.2: Specific Aims Approaches
Aims 1 and 2a were addressed using the TOP/FOP FLASH luciferase reporter
assay as a read-out of activation of canonical Wnt signaling.

Overexpression of

canonical Wnt ligands (Wnt3a or Wnt8), wild-type β-catenin (β-catenin WT), or a βcatenin mutant (β-catenin*), or lithium chloride (LiCl) treatment were used to activate
TOP/FOP FLASH reporter activity in human embryonic kidney (HEK293T) cells. LiCl
inhibits GSK3β, blocking phosphorylation of β-catenin and preventing its degradation by
the UPS

. Similarly, β-catenin* has serine (S)/threoinine (T) to aspartic acid

(Zhang, 2003)

(D) point mutations at Ser33, Ser37, Thr41, and Ser45, and cannot be modified by the
destruction complex. Expression of a mouse ephrin-B1 ligand lacking the cytoplasmic
domain, ephrin-B1ΔC, in the presence of an activator of canonical Wnt (overexpression
of Wnt ligands, β-catenin, or β-catenin*, or LiCl treatment) was tested to determine if
ephrin-B antagonism of canonical Wnt signaling reported in Xenopus is conserved in
mammals, and whether or not this effect depends on the normal function of the
endogenous regulation of β-catenin stability via GSK3β.
Aim 2a was addressed by measuring changes in total cellular β-catenin in
HEK293T cell lysates in response to canonical Wnt and ephrin-B signaling.
relevant Western blots were quantified using Image J

The

(Schindelin, 2012; Walter, 2010; Eliceiri, 2012)

.

In accordance with Aim 2b, the subcellular localization of β-catenin was observed using
confocal immunofluorescence microscopy. These images were prepared and analyzed
using the image analysis software Adobe Illustrator, Fiji (Image J), and Vaa3d

(Schindelin,

2012; Walter, 2010; Eliceiri, 2012; Peng, 2010; Peng, 2014)

. This analysis allowed visualization of the

subcellular localization of β-catenin (in 3-D) in response to canonical Wnt and ephrin-B
signaling.
Aim 3 was addressed by investigating the role of JNK in mediating the ephrin-B
antagonism of canonical Wnt signaling. The activation of JNK by ephrin-B signaling
was reaffirmed using an in vitro JNK assay

(Christian et al., unpublished data)

. Inhibition of JNK

using the JNK inhibitor, SP600125, and analysis of the corresponding effects on LiCl induced activation of canonical Wnt signaling (TOP/FOP FLASH) was used to indicate
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whether or not inhibition of JNK activity is sufficient to reverse the antagonistic effect of
ephrin-B on canonical Wnt signaling (Bennett, 2001).
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Chapter 3: Methods
A

combination

of

cell-based

assays,

biochemical

techniques,

and

confocal

immunofluorescence microscopy in HEK293T cells were used to investigate the
molecular mechanisms of ephrin-B antagonism of canonical Wnt signaling.
pCS2 vector-based plasmids were constructed previously including Mus
musculus HA-ephrin-B1ΔC (ephrin-B1ΔC), wild-type Xenopus laevis β-catenin (βcateninWT), a mutant Xenopus laevis β-catenin that is constitutively active, β-catenin*
(S33/37/41/T45D), Wnt3a, and Wnt8.

In addition, pTOP FLASH (TOP) and pFOP

FLASH (FOP) luciferase reporter plasmids were obtained commercially (EMD Millipore;
21-170).
HEK293T cells were seeded and grown in Dulbecco’s Modified Eagle Medium
(DMEM) high glucose (Gibco; 11965-092) supplemented with 5% fetal bovine serum
(FBS) and 1:100 penn/strep at a controlled density for ~24 hours. When the pan-JNK
inhibitor, SP600125 (abcam; ab120065), was used, it was mixed with fresh DMEM
media, and added to the appropriate wells, replacing the existing media after ~24 hours
of growth post-seeding. Auto H20 (vehicle control for LiCl) and DMSO vehicle controls
were added in the same fashion as SP60125, as necessary, to evaluate any potential
effects of these vehicles on the results. Lipofectamine-based transfections (Invitrogen;
L3000015) of these plasmids were performed after ~24 hours of growth post-seeding.
For immunofluorescence experiments, the cells were grown on poly-D-lysine (molecular
weight 70,000-150,000) coated coverslips (Sigma; P6407). Following transfection, the
cells were incubated at 37°C for ~24 hours. The cells were then harvested and lysed in
preparation for TOP/FOP FLASH luciferase reporter assay, Western blot, or other
biochemical analysis, or fixed in preparation for immunofluorescence treatment and
confocal microscopy.
The TOP/FOP FLASH luciferase reporter assay was performed according to the
manufacturer’s protocol and recommendation (Promega; E1500). The Spectra max
GeminiXPS plate reader and the SoftMax Pro 6 software from Molecular Devices were
used in luminescence mode to measure the luminescence in relative luminescence
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units (RLU) of the assayed cell lysate samples. The average and standard deviation of
the RLU measurements of three replicates of each treatment performed in parallel were
calculated using Microsoft Excel.
The Western blots were blocked with 5% bovine serum albumin (BSA) for one
hour at room temperature with shaking. Polyclonal rabbit α β-catenin (Sigma; C2206)
was applied at a dilution of 1:4,000 and incubated overnight at 4°C with shaking.
Polyclonal goat α rabbit horseradish peroxidase (HRP) secondary antibody (Sigma;
A0545) was applied to each Western blot at a dilution of 1:25,000, and incubated for 30
minutes at room temperature with shaking. The HRP substrate was applied, and the
Western blots were imaged using the ProteinSimple FluorChem Q system and the
AlphaView 3.4.0 software. The Western blots were stripped and blotted for β-actin by
applying monoclonal mouse α β-actin HRP clone AC-15 (Sigma; A3854) at a dilution of
1:25,000, and incubated for 30 min at room temperature with shaking.

The HRP

substrate was applied and the Western blots were imaged as described above. Two of
the three Western blots were re-stripped and blotted for E-cadherin by applying
monoclonal rabbit α E-cadherin clone 24E10 (Cell Signaling Technology; 3195) at a
dilution of 1:1,000, and incubating overnight at 4°C with shaking. The HRP substrate
was applied to the Western blots and they were imaged as described above. The
Western blot images were quantified by calculating the integrated density of each band
using the Image analysis software Image J

(Schindelin, 2012; Walter, 2010; Eliceiri, 2012)

. The

normalized values (adjusted relative density) of the signals were obtained by dividing
the integrated density of the protein of interest band by the integrated density of the βactin band of that same sample. The average and standard deviation of the adjusted
relative density values of β-catenin under each treatment from three replicate Western
blots were calculated.
For immunofluorescence, the cells were fixed with 1:1 methanol:acetone. The
cells were blocked with blocking buffer (5% lamb serum, 0.3% Triton X-100 in 1x
phosphate buffered saline (PBS)) for one hour at room temperature in a humid, lighttight box. Polyclonal rabbit α β-catenin (Sigma; C2206) and monoclonal mouse α HA
clone HA-7 (Sigma; H9658) primary antibodies were applied at dilutions of 1:1000 as
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necessary, and incubated overnight at 4°C in a humid, light-tight box. Donkey α rabbit
CF633 (Biotium; 20125) and polyclonal donkey α mouse Alexa 488 (Jackson
ImmunoResearch Laboratories; 715-545-150) fluorescently conjugated secondary
antibodies were each applied at the concentration 10 µg/mL, as necessary, to label βcatenin and ephrin-B1ΔC (HA), respectively, and incubated for one hour at room
temperature in a humid, light-tight box. The coverslips on which the cells were grown
and fixed were mounted onto a microscope slide using Vectashield (Vector
Laboratories; H-1000). The slides were imaged via Z-scan at 600x magnification using
an Olympus Fluoview FV1000 confocal microscope and the Olympus Fluoview 4.1
software. Following fluorescent microscopy, the images obtained were prepared and
analyzed using the imaging software Adobe Illustrator, Fiji (Image J), and Vaa3d
(Schindelin, 2012; Walter, 2010; Eliceiri, 2012; Peng, 2010; Peng, 2014)

.
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Chapter 4: Results
Overexpression of the canonical Wnt ligands Wnt3a and Wnt8 was not sufficient
to induce TOP/FOP FLASH reporter activity (Figures 11 and 12). Overexpression of
wild-type β-catenin (β-cateninWT), however, was sufficient to induce TOP/FOP FLASH
reporter activity (Figure 13).

Co-expression of mouse ephrin-B1ΔC inhibited β-

cateninWT – induced TOP/FOP FLASH reporter activity (Figure 14). Similarly, 24 hour
LiCl treatment induced TOP/FOP FLASH reporter activity (Figure 15), and
overexpression of mouse ephrin-B1ΔC abrogated the LiCl – induced TOP/FOP FLASH
reporter activity (Figure 16). β-catenin* overexpression also induced TOP/FOP FLASH
reporter activity (Figure 17). Co-expression with ephrin-B1ΔC abrogated the β-catenin*
– induced TOP/FOP FLASH reporter activity (Figure 18).
Levels of total cellular β-catenin were deduced by calculating the adjusted
relative density and the average and standard deviation of the adjusted relative density
values of β-catenin under each treatment from three replicate Western blots.

LiCl

treatment results in an increase in total cellular β-catenin (Figures 19 and 20).
Furthermore, overexpression of ephrinB1ΔC in the presence of LiCl treatment reduced
the increase in total cellular β-catenin observed with LiCl alone (Figures 19 and 20).
However, the increase in total cellular β-catenin upon LiCl treatment and the reduction
of this effect with the addition of overexpression of ephrin-B1ΔC, as measured by the
adjusted relative density of α β-catenin in Western blots, varied greatly among
replicates (only one replicate is shown; Figure 19). Indeed, these results were not
statistically significant, as revealed by t-test’s.
Levels of total cellular E-cadherin were deduced by calculating the adjusted
relative density values of E-cadherin under each treatment from two replicate Western
blots (one replicate is shown; Figure 21).
response to LiCl treatment Figure 21).

Total cellular E-cadherin increased in

Total cellular E-cadherin also increased in

response to ephrin-B1ΔC overexpression (Figure 21). In one replicate Western blot for
E-cadherin, overexpression of ephrin-B1ΔC together with LiCl treatment did not affect
the increase in total cellular E-cadherin observed in response to LiCl treatment alone
(Figure 21) However, in another replicate Western blot for total cellular E-cadherin,
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overexpression of ephrin-B1ΔC together with 50 mM LiCl enhanced the observed
increase in total cellular E-cadherin (data not shown). However, more experiments
need to be performed to verify these effects.
Analysis of β-catenin subcellular localization using confocal immunofluorescence
microscopy revealed that β-catenin subcellular localization varies in apical, middle, and
basal Z-sections of HEK293T cells cultured to confluency (Figure 22).

Membrane-

localized β-catenin is very prominent at apical Z-sections, and is also apparent at basal
Z-sections (Figure 22-25).

Cytoplasmic β-catenin is observed in all Z-positions,

however, cytoplasmic space is lacking in HEK293T cells, especially once they form cellcell interactions and become more tightly organized (Figure 22-25). Nuclear β-catenin
is observed in some cells in the middle and apical Z-sections, and nuclear β-catenin
punctae are observed in some cells in the apical Z-sections, particularly (Figure 22-25).
LiCl treatment may enhance membrane localization of β-catenin at basal and, more
prominently, apical Z-sections, and may enhance nuclear β-catenin punctae at apical Zsections (Figure 22-25).

Overexpression of ephrinB1ΔC also enhances membrane

localization of β-catenin at basal and apical Z-sections, and the effect is even more
prominent when LiCl treatment is applied in addition to overexpression of ephrin-B1ΔC
(Figure 22-25).
SP600125 does not prevent inhibition of LiCl – induced TOP/FOP FLASH
reporter expression by ephrin-B1ΔC (Figure 26). Rather, SP600125 seems to enhance
the ephrin-B1ΔC antagonism of LiCl – induced TOP/FOP FLASH reporter expression
(Figure 26).
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Figure 11: Wnt3a Overexpression is Not Sufficient to Induce Reporter Activity.
HEK293T cells were grown at a controlled density for ~24 hours. The cells were
transfected with pTOP FLASH (TOP) and pFOP FLASH (FOP) and the indicated
constructs and cultured for ~24 hours. Cell lysates were processed for luciferase
assays. A representative experiment performed in triplicate is shown here. Results are
presented as average ratios of TOP vs. FOP luciferase activity measured as relative
luminescence units (RLU), and the error bars represent standard deviations. *: P < 0.05,
**: P < 0.01, *** P < 0.001.
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Figure 12: Wnt8 Overexpression is Not Sufficient to Induce Reporter Activity.
HEK293T cells were grown at a controlled density for ~24 hours. The cells were
transfected with pTOP FLASH (TOP) and pFOP FLASH (FOP) and the indicated
constructs and cultured for ~24 hours. Cell lysates were processed for luciferase
assays. A representative experiment performed in triplicate is shown here. Results are
presented as average ratios of TOP vs. FOP luciferase activity measured as relative
luminescence units (RLU), and the error bars represent standard deviations. *: P < 0.05,
**: P < 0.01, *** P < 0.001.
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Figure 13: Wild-type β-catenin Overexpression Induces Reporter Activity.
HEK293T cells were grown at a controlled density for ~24 hours. The cells were
transfected with pTOP FLASH (TOP) and pFOP FLASH (FOP) and the indicated
constructs and cultured for ~24 hours. Cell lysates were processed for luciferase
assays. A representative experiment performed in triplicate is shown here. Results are
presented as average ratios of TOP vs. FOP luciferase activity measured as relative
luminescence units (RLU), and the error bars represent standard deviations. *: P < 0.05,
**: P < 0.01, *** P < 0.001.
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Figure 14: ephrin-B1ΔC Inhibits Wild-type β-catenin – Induced Reporter Activity.
HEK293T cells were grown at a controlled density for ~24 hours. The cells were
transfected with pTOP FLASH (TOP) and pFOP FLASH (FOP) and the indicated
constructs and cultured for ~24 hours. Cell lysates were processed for luciferase
assays. A representative experiment performed in triplicate is shown here. Results are
presented as average ratios of TOP vs. FOP luciferase activity measured as relative
luminescence units (RLU), and the error bars represent standard deviations. *: P < 0.05,
**: P < 0.01, *** P < 0.001.
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Figure 15: LiCl Induces Reporter Activity. HEK293T cells were grown at a controlled
density for ~24 hours. The cells were treated with 50 mM LiCl, transfected with pTOP
FLASH (TOP) and pFOP FLASH (FOP) and the indicated constructs, and cultured for
~24 hours. Cell lysates were processed for luciferase assays. A representative
experiment performed in triplicate is shown here. Results are presented as average
ratios of TOP vs. FOP luciferase activity measured as relative luminescence units
(RLU), and the error bars represent standard deviations. *: P < 0.05, **: P < 0.01, *** P
< 0.001.
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Figure 16: ephrin-B1ΔC Inhibits LiCl – Induced Reporter Activity. HEK293T cells
were grown at a controlled density for ~24 hours. The cells were treated with 50 mM
LiCl, transfected with pTOP FLASH (TOP) and pFOP FLASH (FOP) and the indicated
constructs, and cultured for ~24 hours. Cell lysates were processed for luciferase
assays. A representative experiment performed in triplicate is shown here. Results are
presented as average ratios of TOP vs. FOP luciferase activity measured as relative
luminescence units (RLU), and the error bars represent standard deviations. *: P < 0.05,
**: P < 0.01, *** P < 0.001.
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Figure 17: β-catenin* Overexpression Induces Reporter Activity. HEK293T cells
were grown at a controlled density for ~24 hours. The cells were transfected with pTOP
FLASH (TOP) and pFOP FLASH (FOP) and the indicated constructs and cultured for
~24 hours. Cell lysates were processed for luciferase assays. A representative
experiment performed in triplicate is shown here. Results are presented as average
ratios of TOP vs. FOP luciferase activity measured as relative luminescence units
(RLU), and the error bars represent standard deviations. *: P < 0.05, **: P < 0.01, *** P
< 0.001.
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Figure 18: ephrin-B1ΔC Inhibits β-catenin* – Induced Reporter Activity. HEK293T
cells were grown at a controlled density for ~24 hours. The cells were transfected with
pTOP FLASH (TOP) and pFOP FLASH (FOP) and the indicated constructs and cultured
for ~24 hours. Cell lysates were processed for luciferase assays. A representative
experiment performed in triplicate is shown here. Results are presented as average
ratios of TOP vs. FOP luciferase activity measured as relative luminescence units
(RLU), and the error bars represent standard deviations. *: P < 0.05, **: P < 0.01, *** P
< 0.001.
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Figure 19: ephrin-B Signaling Affects Levels of Total Cellular β-catenin. HEK293T
cells were grown at a controlled density for ~24 hours. The cells were treated with 50
mM LiCl, transfected with pTOP FLASH (TOP) and pFOP FLASH (FOP) and the
indicated constructs, and cultured for ~24 hours. Western blots of whole cell lysates
were carried out using α β-catenin. The Western blots were stripped and blotted for α βactin. The adjusted relative density of each β-catenin band was calculated using Fiji,
and normalized (to obtain the adjusted relative density) for the relative amount of cell
lysate by dividing the integrated density of each β-catenin band by the respective
integrated density of the respective β-actin band and setting the adjusted relative
density of the negative control group to 1.
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Figure 20: ephrin-B Signaling Affects Levels of Total Cellular β-catenin. The
averages and standard deviations of the adjusted relative densities of α β-catenin from
three Western blots of cell lysates from three biological replicates of each treatment
performed in parallel was calculated.
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Figure 21: LiCl and ephrin-B Signaling Increase Levels of Total Cellular
E-cadherin Independently and Co-Treatment Does Not Influence this Effect.
HEK293T cells were grown at a controlled density for ~24 hours. The cells were treated
with 50 mM LiCl, transfected with pTOP FLASH (TOP) and pFOP FLASH (FOP) and
the indicated constructs, and cultured for ~24 hours. Two of the Western blots of whole
cell lysates blotted for α β-catenin and α β-actin were re-stripped and blotted for α Ecadherin (hence, α β-actin image is reproduced from Figure 19), and one of these
Western blots is shown. The adjusted relative density of each β-catenin band was
calculated using Fiji, and normalized (to obtain the adjusted relative density) for the
relative amount of cell lysate by dividing the integrated density of each β-catenin band
by the respective integrated density of the respective β-actin band and setting the
adjusted relative density of the negative control group to 1.
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Figure 22: Subcellular Localization of β-catenin in Response to ephrin-B Signaling in Apical, Middle, and
Basal Z Sections. HEK293T cells were grown at a controlled density for ~24 hours. The cells were treated with
50 mM LiCl, transfected with the indicated constructs, and cultured for ~24 hours. The cells were fixed in 1:1
methanol:acetone, and blocked with blocking buffer for one hour at room temperature. Primary antibodies were
applied, and incubated overnight at 4°C. Fluorescently conjugated secondary antibodies were each applied at
the concentration 10 µg/mL, as necessary, and incubated for one hour at room temperature. The cells were
imaged via Z-scan at 600x magnification using an Olympus Fluoview FV1000 confocal microscope. Following
fluorescent microscopy, the images obtained were prepared and analyzed using the imaging software Adobe
Illustrator, Fiji (Image J), and Vaa3d. The subcellular localization of endogenous β-catenin is shown in
representative apical, middle, and basal Z-sections for each treatment.
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Figure 23: Subcellular Localization of β-catenin in Response to ephrin-B Signaling in Apical Z Sections.
HEK293T cells were grown at a controlled density for ~24 hours. The cells were treated with 50 mM LiCl, transfected
with the indicated constructs, and cultured for ~24 hours. The cells were fixed in 1:1 methanol:acetone, and blocked
with blocking buffer for one hour at room temperature. Primary antibodies were applied, and incubated overnight at
4°C. Fluorescently conjugated secondary antibodies were each applied at the concentration 10 µg/mL, as necessary,
and incubated for one hour at room temperature. The cells were imaged via Z-scan at 600x magnification using an
Olympus Fluoview FV1000 confocal microscope. Following fluorescent microscopy, the images obtained were
prepared and analyzed using the imaging software Adobe Illustrator, Fiji (Image J), and Vaa3d. The subcellular
localization of endogenous β-catenin and HA-ephrin-B1ΔC is shown in representative apical Z-sections for each
treatment.
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Figure 24: Subcellular Localization of β-catenin in Response to ephrin-B Signaling in Middle Z Sections.
HEK293T cells were grown at a controlled density for ~24 hours. The cells were treated with 50 mM LiCl, transfected
with the indicated constructs, and cultured for ~24 hours. The cells were fixed in 1:1 methanol:acetone, and blocked
with blocking buffer for one hour at room temperature. Primary antibodies were applied, and incubated overnight at
4°C. Fluorescently conjugated secondary antibodies were each applied at the concentration 10 µg/mL, as necessary,
and incubated for one hour at room temperature. The cells were imaged via Z-scan at 600x magnification using an
Olympus Fluoview FV1000 confocal microscope. Following fluorescent microscopy, the images obtained were
prepared and analyzed using the imaging software Adobe Illustrator, Fiji (Image J), and Vaa3d. The subcellular
localization of endogenous β-catenin and HA-ephrin-B1ΔC is shown in representative middle Z-sections for each
treatment.
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Figure 25: Subcellular Localization of β-catenin in Response to ephrin-B Signaling in Basal Z Sections.
HEK293T cells were grown at a controlled density for ~24 hours. The cells were treated with 50 mM LiCl, transfected
with the indicated constructs, and cultured for ~24 hours. The cells were fixed in 1:1 methanol:acetone, and blocked
with blocking buffer for one hour at room temperature. Primary antibodies were applied, and incubated overnight at
4°C. Fluorescently conjugated secondary antibodies were each applied at the concentration 10 µg/mL, as necessary,
and incubated for one hour at room temperature. The cells were imaged via Z-scan at 600x magnification using an
Olympus Fluoview FV1000 confocal microscope. Following fluorescent microscopy, the images obtained were
prepared and analyzed using the imaging software Adobe Illustrator, Fiji (Image J), and Vaa3d. The subcellular
localization of endogenous β-catenin and HA-ephrin-B1ΔC is shown in representative basal Z-sections for each
treatment.
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Figure 26: Inhibition of c-Jun N-terminal kinase (JNK) Inhibits LiCl – Induced
Reporter Activity and Enhances the ephrin-B1ΔC Inhibition of LiCl – Induced
Reporter Activity. HEK293T cells were grown at a controlled density for ~24 hours.
50 µM SP600125 (pan-JNK inhibitor), 0.1% DMSO (vehicle control for SP600125), or
0.01% auto H20 (vehicle control for LiCl) were added to fresh DMEM, and the media of
the cells was replaced as necessary. The cells were treated with 50 mM LiCl,
transfected with pTOP FLASH (TOP) and pFOP FLASH (FOP) and the indicated
constructs, and cultured for ~24 hours. Cell lysates were processed for luciferase
assays. A representative experiment performed in triplicate is shown here. Results are
presented as average ratios of TOP vs. FOP luciferase activity measured as relative
luminescence units (RLU), and the error bars represent standard deviations. *: P < 0.05,
**: P < 0.01, *** P < 0.001.
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Chapter 5: Discussion
As described earlier, the ephrin-B antagonism of canonical Wnt signaling was
initially suggested in a TOP/FOP FLASH assay in HEK293T cells using Xenopus
ephrin-B1 and ephrin-B1ΔC.

Therefore, we aimed to validate this novel interaction

using a TOP/FOP FLASH assay in HEK293T cells using Mus musculus constructs in
order to determine if this interaction is evolutionarily conserved in mammals.
Overexpression of mammalian ephrin-B1ΔC in HEK293T cells inhibits TOP/FOP
FLASH reporter activity induced by the application of LiCl, and overexpression of
mammalian WT β-catenin and β-catenin* (Figures 16,14, and 18).

These results

suggest that the ephrin-B antagonism of canonical Wnt signaling is evolutionarily
conserved between amphibians and mammals.
Because ephrin-Bs can mediate both forward and reverse signaling, we
employed two ephrin-B constructs to determine whether forward or reverse ephrin-B
signaling is responsible for the ephrin-B mediated antagonism of canonical Wnt
signaling. Ephrin-B1 mediates both forward and reverse signaling, while ephrin-B1ΔC
mediates forward signaling, and when overexpressed, can dominant-negatively inhibit
reverse signaling. Because ephrin-B1 and ephrin-B1ΔC had similar effects on LiCl, βcateninWT, and β-catenin* - induced TOP/FOP FLASH reporter activity, we propose
that the ephrin-B antagonism of canonical Wnt signaling in HEK293T cells is likely relies
on forward, rather than reverse, ephrin-B signaling (Figures 16, 14, and 18; ephrin-B1
data: Perfetto et al. unpublished data).
Due to the central role of β-catenin in canonical Wnt signaling, we hypothesized
that the ephrin-B antagonism of canonical Wnt signaling likely involves an alteration of
the stability and/or subcellular localization of β-catenin.

To determine whether the

ephrin-B antagonism of canonical Wnt signaling is dependent on the destruction
complex-mediated degradation of β-catenin, we employed LiCl, which activates
canonical Wnt signaling by inhibiting GSK3β, thereby preventing the degradation of βcatenin whether it is newly synthesized β-catenin or β-catenin released from other
interactors. We also employed a β-catenin mutant described previously, β-catenin* that
has mutations in the GSK3β-targeted sites and hence cannot be modified by the
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destruction complex. Overexpression of ephrin-B1ΔC inhibits LiCl-induced TOP/FOP
FLASH activity in HEK293T cells (Figure 16). Similarly, overexpression of ephrin-B1ΔC
inhibits β-catenin* - induced TOP/FOP FLASH activity in HEK293T cells (Figure 18).
Taken together, these results suggest that the ephrin-B can antagonize canonical Wnt
signaling independently of the β-catenin destruction complex, and likely inhibits
canonical Wnt signaling downstream of the destruction complex. However, we cannot
rule out additional effects upstream or at the level of regulation of β-catenin stability via
GSK3β and the β-catenin destruction complex.

In line with this latter hypothesis,

Western blots for β-catenin indicate that the ephrin-B antagonism of canonical Wnt
signaling may involve a reduction in total cellular β-catenin levels (Figures 19 and 20).
We employed immunofluorescence microscopy to investigate the effects of
ephrin-B signaling on the subcellular localization of β-catenin.

As shown in 22-25,

ephrin-B signaling may affect β-catenin subcellular localization, increasing the relative
amount of β-catenin at the cell membrane.

Because total cellular β-catenin is

distributed among membrane-bound, cytosolic and nuclear pools, an increase in the
membrane-bound pool may result in reduction of the nuclear pool of β-catenin, which is
the only fraction that is functional in mediating canonical Wnt signaling. To further test
this hypothesis, we are in the process of quantifying functional β-catenin in HEK293T
cells with and without ectopic ephrin-B1ΔC by purifying nuclear proteins from the cell
lysates.
JNK is activated downstream of ephrin-B signaling and JNK 1 and 2 directly
interact with and phosphorylate β-catenin.

However, there are conflicting reports

regarding the result of the JNK-phosphorylation of β-catenin

(Hu, 2008; Hu, 2009; Liao, 2006; Wu,

. In addition, JNK 1 and 2- phosphorylation of β-catenin may have opposite effects.

2008)

We confirmed that JNK is activated in response to ephrin-B signaling in HEK293T cells
using a JNK Assay Kit (Figure 9). Furthermore, we employed the pan-JNK inhibitor,
SP600125, to determine if JNK activity is required for the ephrin-B antagonism of
canonical Wnt signaling. As shown in Figure 26, inhibition of JNK using SP600125
does not prevent the ephrin-B – mediated inhibition of LiCl or β-catenin* – induced
TOP/FOP FLASH activity, but rather seems to enhance the effect (Figure 26).

In
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addition, inhibition of JNK alone inhibits LiCl – induced TOP/FOP FLASH activity (Figure
26). This result is consistent with reports that JNK-phosphorylation of β-catenin results
in nuclear accumulation of β-catenin, and activates canonical Wnt signaling in HEK293T
cells

(Wu, 2008)

. Future efforts will be focused on testing if other effectors of forward

ephrin-B signaling, such as RhoA and Rac1, contribute to the inhibition of canonical Wnt
signaling.
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